VitroScan presented twice at the AACR2026 annual meeting

22 April 2026

Proud to see our very own Felix Behr, PhD presenting twice at the recent #AACR2026 annual meeting with both an oral and a poster presentation showcasing how our ex vivo micro-tumor platform can help characterize and predict patient-specific responses to ADCs and immunotherapies.

Particularly exciting to see the growing momentum around patient-derived cancer models and their potential to improve translational research and personalized treatment decisions.

Did we spark your interest? The AACR poster can be downloaded here.